These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 64272)

  • 21. [Status of the therapy of multiple sclerosis].
    Bas H
    Ther Ggw; 1967 Oct; 106(10):1319-25. PubMed ID: 4314784
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiple sclerosis: an overview.
    Rose AS
    Adv Neurol; 1981; 31():3-9. PubMed ID: 7325046
    [No Abstract]   [Full Text] [Related]  

  • 23. Transfer factor. General aspects.
    Grob PJ
    Acta Neurol Scand Suppl; 1977; 63():217-26. PubMed ID: 322440
    [No Abstract]   [Full Text] [Related]  

  • 24. Multiple sclerosis:therapeutic strategies.
    Scheinberg LC
    Ann Neurol; 1994; 36 Suppl():S122. PubMed ID: 8017872
    [No Abstract]   [Full Text] [Related]  

  • 25. Transfer-factor therapy in multiple sclerosis.
    Behan PO; Durward WF; Melville ID; McGeorge AP; Behan WM
    Lancet; 1976 May; 1(7967):988-90. PubMed ID: 57441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Symptomatic therapy of multiple sclerosis].
    Henze T
    Nervenarzt; 2004 Aug; 75 Suppl 1():2-39. PubMed ID: 15480526
    [No Abstract]   [Full Text] [Related]  

  • 27. Immunological treatment in multiple sclerosis.
    Lancet; 1980 Nov; 2(8201):953-4. PubMed ID: 6107593
    [No Abstract]   [Full Text] [Related]  

  • 28. Emerging treatments in multiple sclerosis.
    Schluep M; Bogousslavsky J
    Eur Neurol; 1997; 38(3):216-21. PubMed ID: 9363834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Proceedings: Immunologic studies with transfer factor in multiple sclerosis patients.
    Zabriskie JB; Utermohlen V; Espinoza LR; Plank CR; Collins RC
    Neurology; 1975 May; 25(5):490. PubMed ID: 1169711
    [No Abstract]   [Full Text] [Related]  

  • 30. Combination therapy for multiple sclerosis: the treatment strategy of the future?
    Weinstock-Guttman B; Bakshi R
    CNS Drugs; 2004; 18(12):777-92. PubMed ID: 15377168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The use of transfer factors in the treatment of multiple sclerosis: a case report.
    Sacks N; Potgieter HJ; Van Rensburg AJ
    S Afr Med J; 1976 Sep; 50(40):1556-8. PubMed ID: 982209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immunotherapy in multiple sclerosis].
    Cendrowski W
    Pol Tyg Lek; 1980 Mar; 35(9):237-8. PubMed ID: 6445060
    [No Abstract]   [Full Text] [Related]  

  • 33. New Approaches to the Diagnosis, Clinical Course, and Goals of Therapy in Multiple Sclerosis and Related Disorders.
    Krieger SC
    Continuum (Minneap Minn); 2016 Jun; 22(3):723-9. PubMed ID: 27261678
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of disseminated sclerosis with Bogomolet's serum].
    NIKOEVSKI P; TEPTSIEVA M; RUSKOVA T
    Suvr Med (Sofiia); 1957; 8(12):104-9. PubMed ID: 13569151
    [No Abstract]   [Full Text] [Related]  

  • 35. “Benefit-risk analysis of glatiramer acetate for relapsing-remitting and clinically isolated syndrome multiple sclerosis” by Qizilbash et al.
    Villoro R
    Clin Ther; 2013 Jan; 35(1):94-5. PubMed ID: 23328271
    [No Abstract]   [Full Text] [Related]  

  • 36. [Therapy of MS symptoms. Here also are guidelines necessary].
    Henze T; Toyka KV
    Nervenarzt; 2004 Aug; 75 Suppl 1():S1. PubMed ID: 15480525
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind trial of transfer factor vs placebo in multiple sclerosis patients.
    Collins RC; Espinoza LR; Plank CR; Ebers GC; Rosenberg RA; Zabriskie JB
    Clin Exp Immunol; 1978 Jul; 33(1):1-11. PubMed ID: 361313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polyunsaturated fatty acids in treatment of acute remitting multiple sclerosis.
    Bates D; Fawcett PR; Shaw DA; Weightman D
    Br Med J; 1978 Nov; 2(6149):1390-1. PubMed ID: 363236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Multiple sclerosis--what should be done?].
    Kesselring J
    Ther Umsch; 1993 Nov; 50(11):766-70. PubMed ID: 7514811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunological aspects of multiple sclerosis.
    Hughes RA
    Br J Hosp Med; 1977 Nov; 18(5):467-8, 470, 473-6. PubMed ID: 597658
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.